These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
431 related items for PubMed ID: 15701438
1. Heart transplant and left ventricular assist device costs. Digiorgi PL, Reel MS, Thornton B, Burton E, Naka Y, Oz MC. J Heart Lung Transplant; 2005 Feb; 24(2):200-4. PubMed ID: 15701438 [Abstract] [Full Text] [Related]
2. Costs and reimbursement gaps after implementation of third-generation left ventricular assist devices. Mishra V, Geiran O, Fiane AE, Sørensen G, Andresen S, Olsen EK, Khushi I, Hagen TP. J Heart Lung Transplant; 2010 Jan; 29(1):72-8. PubMed ID: 19783175 [Abstract] [Full Text] [Related]
3. Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era. Miller LW, Nelson KE, Bostic RR, Tong K, Slaughter MS, Long JW. J Heart Lung Transplant; 2006 Jul; 25(7):778-84. PubMed ID: 16818120 [Abstract] [Full Text] [Related]
4. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. Dang NC, Topkara VK, Mercando M, Kay J, Kruger KH, Aboodi MS, Oz MC, Naka Y. J Heart Lung Transplant; 2006 Jan; 25(1):1-6. PubMed ID: 16399523 [Abstract] [Full Text] [Related]
5. Relationship of nutritional status to length of stay, hospital costs, and discharge status of patients hospitalized in the medicine service. Chima CS, Barco K, Dewitt ML, Maeda M, Teran JC, Mullen KD. J Am Diet Assoc; 1997 Sep; 97(9):975-8; quiz 979-80. PubMed ID: 9284874 [Abstract] [Full Text] [Related]
6. Evolving costs of long-term left ventricular assist device implantation. Gelijns AC, Richards AF, Williams DL, Oz MC, Oliveira J, Moskowitz AJ. Ann Thorac Surg; 1997 Nov; 64(5):1312-9. PubMed ID: 9386696 [Abstract] [Full Text] [Related]
7. Temporal changes in hospital costs for left ventricular assist device implantation. Slaughter MS, Bostic R, Tong K, Russo M, Rogers JG. J Card Surg; 2011 Sep; 26(5):535-41. PubMed ID: 21848578 [Abstract] [Full Text] [Related]
8. Multidisciplinary approach decreases length of stay and reduces cost for ventricular assist device therapy. Murray MA, Osaki S, Edwards NM, Johnson MR, Bobadilla JL, Gordon EA, Sanderfoot M, Kohmoto T. Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):84-8. PubMed ID: 18940829 [Abstract] [Full Text] [Related]
9. Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure. Long EF, Swain GW, Mangi AA. Circ Heart Fail; 2014 May; 7(3):470-8. PubMed ID: 24563450 [Abstract] [Full Text] [Related]
10. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant? Klotz S, Stypmann J, Welp H, Schmid C, Drees G, Rukosujew A, Scheld HH. Ann Thorac Surg; 2006 Nov; 82(5):1774-8. PubMed ID: 17062246 [Abstract] [Full Text] [Related]
11. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L. Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167 [Abstract] [Full Text] [Related]
12. Surgical ventricular restoration versus cardiac transplantation: a comparison of cost, outcomes, and survival. Williams JA, Weiss ES, Patel ND, Nwakanma LU, Reeb BE, Conte JV. J Card Fail; 2008 Sep; 14(7):547-54. PubMed ID: 18722319 [Abstract] [Full Text] [Related]
13. Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy. Rogers JG, Bostic RR, Tong KB, Adamson R, Russo M, Slaughter MS. Circ Heart Fail; 2012 Jan; 5(1):10-6. PubMed ID: 22052901 [Abstract] [Full Text] [Related]
14. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices. Radovancevic B, Vrtovec B, de Kort E, Radovancevic R, Gregoric ID, Frazier OH. J Heart Lung Transplant; 2007 Aug; 26(8):815-8. PubMed ID: 17692785 [Abstract] [Full Text] [Related]
15. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes. Baumwol J, Macdonald PS, Keogh AM, Kotlyar E, Spratt P, Jansz P, Hayward CS. J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314 [Abstract] [Full Text] [Related]
16. Effect of left ventricular assist device infection on post-transplant outcomes. Schulman AR, Martens TP, Russo MJ, Christos PJ, Gordon RJ, Lowy FD, Oz MC, Naka Y. J Heart Lung Transplant; 2009 Mar; 28(3):237-42. PubMed ID: 19285614 [Abstract] [Full Text] [Related]
17. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices. Patel ND, Weiss ES, Schaffer J, Ullrich SL, Rivard DC, Shah AS, Russell SD, Conte JV. Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570 [Abstract] [Full Text] [Related]
18. Costs associated with ventricular assist device use in children. Mahle WT, Ianucci G, Vincent RN, Kanter KR. Ann Thorac Surg; 2008 Nov; 86(5):1592-7. PubMed ID: 19049755 [Abstract] [Full Text] [Related]
19. Improved survival after heart transplantation in patients with bridge to transplant in the recent era: a 17-year single-center experience. Osaki S, Edwards NM, Johnson MR, Velez M, Munoz A, Lozonschi L, Murray MA, Proebstle AK, Kohmoto T. J Heart Lung Transplant; 2009 Jun; 28(6):591-7. PubMed ID: 19481020 [Abstract] [Full Text] [Related]
20. A hospital perspective on the cost-effectiveness of beta-blockade for prophylaxis of atrial fibrillation after cardiothoracic surgery. Gillespie EL, White CM, Kluger J, Sahni J, Gallagher R, Coleman CI. Clin Ther; 2005 Dec; 27(12):1963-9. PubMed ID: 16507383 [Abstract] [Full Text] [Related] Page: [Next] [New Search]